Development and validation of prognostic index based on immunogenic cell death-related genes with melanoma

Development and validation of prognostic index based on immunogenic cell death-related genes with melanoma

Although immune checkpoint inhibitors have improved the overall survival rate of skin cutaneous melanoma (SKCM) patients, there is a wide variation and low response rate to these treatments in clinical immunotherapy for melanoma patients. These problems can be addressed through the induction of immu...

Full description

Bibliographic Details
Main Authors:	Yajun Han, Qinqin Cai, Xiaolin Xie, Shilong Gao, Xiwen Fan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Oncology
Subjects:	immunogenic cell death melanoma prognosis tumor microenvionment immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1011046/full

Similar Items

An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma
by: Xinwen Wang, et al.
Published: (2021-11-01)

Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma
by: Yuanyuan Hu, et al.
Published: (2022-11-01)

Nanocarrier-Mediated Immunogenic Cell Death for Melanoma Treatment
by: Wang J, et al.
Published: (2023-12-01)

The prognostic value and response to immunotherapy of immunogenic cell death-associated genes in breast cancer
by: Rongling Zhao, et al.
Published: (2023-02-01)

Comprehensive characterisation of immunogenic cell death in melanoma revealing the association with prognosis and tumor immune microenvironment
by: Jie Ren, et al.
Published: (2022-09-01)

Identification of Immunogenic Cell-Death-Related Subtypes and Development of a Prognostic Signature in Gastric Cancer
by: Xuejun Gan, et al.
Published: (2023-03-01)

Chromomycin A5 induces bona fide immunogenic cell death in melanoma
by: Katharine Gurgel Dias Florêncio, et al.
Published: (2022-11-01)

Exploring the prognostic significance of immunogenic cell death‐related genes as risk biomarkers in cervical cancer
by: Shuangmei Jin, et al.
Published: (2024-06-01)

A novel immunogenic cell death signature for the prediction of prognosis and therapies in glioma
by: Jianhua Zhang, et al.
Published: (2023-07-01)

Immunogenic cell death (ICD) genes predict immunotherapy response and therapeutic targets in acute myeloid leukemia (AML)
by: Shuang Wen, et al.
Published: (2024-08-01)

Immunogenic cell death-related classifications in breast cancer identify precise immunotherapy biomarkers and enable prognostic stratification
by: Xue Wang, et al.
Published: (2022-11-01)

Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
by: Ken Maes, et al.
Published: (2019-07-01)

Focus on pattern recognition receptors to identify prognosis and immune microenvironment in colon cancer
by: Pengtao Ren, et al.
Published: (2022-09-01)

Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma
by: Praveen K. Bommareddy, et al.
Published: (2019-07-01)

Immunogenic cell death signatures from on-treatment tumor specimens predict immune checkpoint therapy response in metastatic melanoma
by: Huancheng Zeng, et al.
Published: (2024-10-01)

Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma
by: Xiaotian He, et al.
Published: (2023-06-01)

Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer
by: Xi Cao, et al.
Published: (2022-10-01)

A novel immunogenic cell death–related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer
by: Bingqi Dong, et al.
Published: (2023-05-01)

Pan‐cancer analyses of immunogenic cell death‐derived gene signatures: Potential biomarkers for prognosis and immunotherapy
by: Xiaodan Han, et al.
Published: (2024-04-01)

Uncovering the immunotherapeutic cycle initiated by p19Arf and interferon-β gene transfer to cancer cells: An inducer of immunogenic cell death
by: Ruan F. V. Medrano, et al.
Published: (2017-07-01)

Upregulated Immunogenic Cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor Prognosis in High-Grade Gliomas
by: Xin Tang, et al.
Published: (2022-11-01)

Identification and Validation of Novel Immunogenic Cell Death- and DNA Damage Response-Related Molecular Patterns Correlated with Immune Status and Prognosis in Hepatocellular Carcinoma
by: Xiaokai Zhang, et al.
Published: (2023-01-01)

Prognostic and therapeutic insights into colorectal carcinoma through immunogenic cell death gene profiling
by: Jinglu Yu, et al.
Published: (2024-06-01)

Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM
by: Songshan Feng, et al.
Published: (2022-09-01)

Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma
by: Jiayang Cai, et al.
Published: (2022-10-01)

Construction of an immunogenic cell death-based risk score prognosis model in breast cancer
by: Yanling Li, et al.
Published: (2022-12-01)

Genomic analysis of immunogenic cell death-related subtypes for predicting prognosis and immunotherapy outcomes in glioblastoma multiforme
by: Liu Zhiye, et al.
Published: (2023-06-01)

Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma
by: Yingshu Cui, et al.
Published: (2023-08-01)

Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death
by: Xuhui Bao, et al.
Published: (2022-07-01)

Significance of immunogenic cell death-related genes in prognosis prediction and immune microenvironment landscape of patients with cutaneous melanoma
by: Weijiang Fu, et al.
Published: (2022-09-01)

Carbon ion radiotherapy triggers immunogenic cell death and sensitizes melanoma to anti-PD-1 therapy in mice
by: Heng Zhou, et al.
Published: (2022-12-01)

The Prognostic Value and Potential Immune Mechanisms of lncRNAs Related to Immunogenic Cell Death in Papillary Thyroid Carcinoma
by: Wang Y, et al.
Published: (2024-03-01)

Construction of immunogenic cell death-related molecular subtypes and prognostic signature in colorectal cancer
by: Yu Chun, et al.
Published: (2023-11-01)

Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes
by: Samuel I. Kim, et al.
Published: (2021-02-01)

Nanotechnology-Assisted Immunogenic Cell Death for Effective Cancer Immunotherapy
by: Yichen Guo, et al.
Published: (2023-08-01)

Bioinformatics analysis and validation of genes related to paclitaxel's anti-breast cancer effect through immunogenic cell death
by: Qianmei Yang, et al.
Published: (2024-04-01)

Immunogenic cell death: A new strategy to enhancing cancer immunotherapy
by: Lei Dou, et al.
Published: (2024-12-01)

Silver nanoparticle induced immunogenic cell death can improve immunotherapy
by: Ara Sargsian, et al.
Published: (2024-11-01)

Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing to Identify an Immunogenic Cell Death-Related 5-Gene Prognostic Signature in Hepatocellular Carcinoma
by: Peng L, et al.
Published: (2024-05-01)

STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells
by: Xiaoyan Shao, et al.
Published: (2019-05-01)